Post by
Craigbad on May 03, 2016 8:55am
Bnn
Bnn interviewed the author of the Financial Times article this morning. He didn't think we'd be taken in for hearings in parliament, but figured regulators would likely be looking into the price hikes. Just when you think headline risk is gone a new one arises. I thought this name would eventually decouple from Valeant, but it looks like the media is going to paint us with the same brush rightly or wrongly. Public perception is at an all time low for Turing and Valeant, and it seems the media is going to use their big reach to make Concordia the next pharma bad boy to keep these headlines going. Brutal...........
Comment by
select1011 on May 03, 2016 9:06am
This post has been removed in accordance with Community Policy
Comment by
ohwhatanight on May 03, 2016 9:40am
MT will say nothing until next Friday...... He's not saying a thing until ER. However... I expect to see him on BNN next Friday .... His only defence and offence right now is his earnings reports.... proving his hypothesis that this entire strategy just makes sense.
Comment by
select1011 on May 03, 2016 9:46am
This post has been removed in accordance with Community Policy
Comment by
select1011 on May 03, 2016 10:00am
This post has been removed in accordance with Community Policy
Comment by
ohwhatanight on May 03, 2016 10:03am
In 3 years this company has gone from zero to here. That in itself is unbelievable execution. Can we go to another level from here?? Thats why we are on this board.